Form 4: Guardant Health's Chief Technology Officer Reports Stock Transactions
SEC Form 4 Filing
Darya Chudova, Chief Technology Officer of Guardant Health, reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.
Summary
- Darya Chudova, the Chief Technology Officer of Guardant Health, Inc., filed a Form 4 detailing changes in beneficial ownership.
- On May 15, 2025, 8,705 restricted stock units vested.
- Ms. Chudova disposed of 4,412 shares of common stock at a price of $40.46 to cover tax withholding obligations.
- Following these transactions, Ms. Chudova directly owns 78,798 shares of Guardant Health common stock and 17,411 restricted stock units.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions, which carries a neutral sentiment.
Industry Context
This filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency into the trading activities of key personnel at Guardant Health.
Stakeholder Impact
- The transaction has a minor impact on shareholders as it involves the sale of shares by an executive to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| August 7, 2023 | Date of restricted stock unit award grant. |
| May 15, 2023 | One-year anniversary of the vesting start date. |
| May 15, 2025 | Date of transaction: vesting of restricted stock units and sale of shares for tax obligations. |
| May 16, 2025 | Date of signature for the Form 4 filing. |
Keywords
Form 4, Guardant Health, Chudova, Stock, Restricted Stock Units, Beneficial Ownership, Officer Transactions
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.